Log in

NASDAQ:PGNY - Progyny Stock Price, Forecast & News

$25.16
-1.30 (-4.91 %)
(As of 12/13/2019 02:34 AM ET)
Today's Range
$25.05
Now: $25.16
$27.15
50-Day Range N/A
52-Week Range
$13.29
Now: $25.16
$32.00
Volume656,411 shs
Average Volume811,403 shs
Market Capitalization$2.11 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption expenses for clients and their employees. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PGNY
CUSIPN/A
CIKN/A
Phone212-888-3124

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$105.40 million

Profitability

Miscellaneous

EmployeesN/A
Market Cap$2.11 billion
Next Earnings Date3/4/2020 (Estimated)
OptionableNot Optionable

Receive PGNY News and Ratings via Email

Sign-up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter.


Progyny (NASDAQ:PGNY) Frequently Asked Questions

What is Progyny's stock symbol?

Progyny trades on the NASDAQ under the ticker symbol "PGNY."

How were Progyny's earnings last quarter?

Progyny Inc (NASDAQ:PGNY) issued its quarterly earnings results on Wednesday, December, 4th. The company reported $0.03 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.02 by $0.01. The firm had revenue of $61.20 million for the quarter, compared to analysts' expectations of $60.83 million. The company's revenue for the quarter was up 120.1% compared to the same quarter last year. View Progyny's Earnings History.

When is Progyny's next earnings date?

Progyny is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Progyny.

What guidance has Progyny issued on next quarter's earnings?

Progyny updated its fourth quarter earnings guidance on Wednesday, December, 4th. The company provided earnings per share (EPS) guidance of $0.01 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.03. The company issued revenue guidance of $65.0-$66.5 million, compared to the consensus revenue estimate of $65.94 million.

What price target have analysts set for PGNY?

6 brokerages have issued 1-year price objectives for Progyny's stock. Their forecasts range from $26.00 to $33.00. On average, they expect Progyny's stock price to reach $29.67 in the next year. This suggests a possible upside of 17.9% from the stock's current price. View Analyst Price Targets for Progyny.

What is the consensus analysts' recommendation for Progyny?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Progyny in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Progyny.

Has Progyny been receiving favorable news coverage?

News articles about PGNY stock have trended negative recently, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Progyny earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Progyny.

Who are some of Progyny's key competitors?

What other stocks do shareholders of Progyny own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Progyny investors own include NVIDIA (NVDA), Home Depot (HD), Honeywell International (HON), Alibaba Group (BABA), salesforce.com (CRM), CVS Health (CVS), Prologis (PLD), UnitedHealth Group (UNH), United Technologies (UTX) and Marvell Technology Group (MRVL).

When did Progyny IPO?

(PGNY) raised $150 million in an IPO on Friday, October 25th 2019. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan, Goldman Sachs and BofA Merrill Lynch acted as the underwriters for the IPO and Citigroup, Piper Jaffray, SVB Leerink and TPG Capital were co-managers.

When does Progyny's lock-up period expire?

Progyny's lock-up period expires on Wednesday, April 22nd. Progyny had issued 10,000,000 shares in its IPO on October 25th. The total size of the offering was $130,000,000 based on an initial share price of $13.00. After the expiration of Progyny's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

How do I buy shares of Progyny?

Shares of PGNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Progyny's stock price today?

One share of PGNY stock can currently be purchased for approximately $25.16.

How big of a company is Progyny?

Progyny has a market capitalization of $2.11 billion and generates $105.40 million in revenue each year. View Additional Information About Progyny.

What is Progyny's official website?

The official website for Progyny is http://www.progyny.com/.

How can I contact Progyny?

Progyny's mailing address is 245 5TH AVENUE, NEW YORK NY, 10016. The company can be reached via phone at 212-888-3124 or via email at [email protected]


MarketBeat Community Rating for Progyny (NASDAQ PGNY)

Community Ranking:  4.0 out of 5 (star star star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  30
MarketBeat's community ratings are surveys of what our community members think about Progyny and other stocks. Vote "Outperform" if you believe PGNY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PGNY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel